Cargando…

Cardiovascular biomarkers as predictors of adverse outcomes in chronic Chagas cardiomyopathy

BACKGROUND: Chronic Chagas Cardiomyopathy (CCM) is a unique form of cardiomyopathy compared to other etiologies of heart failure. In CCM, risk prediction based on biomarkers has not been well-studied. We assessed the prognostic value of a biomarker panel to predict a composite outcome (CO), includin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Echeverría, Luis E., Rojas, Lyda Z., Gómez-Ochoa, Sergio Alejandro, Rueda-Ochoa, Oscar L., Sosa-Vesga, Cristian David, Muka, Taulant, Januzzi, James L., Marcus, Rachel, Morillo, Carlos A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553084/ https://www.ncbi.nlm.nih.gov/pubmed/34710112 http://dx.doi.org/10.1371/journal.pone.0258622

Ejemplares similares

Cardiovascular Biomarkers and Diastolic Dysfunction in Patients With Chronic Chagas Cardiomyopathy
por: Echeverría, Luis E., et al.
Publicado: (2021)

Circulating MicroRNAs and myocardial involvement severity in chronic Chagas cardiomyopathy
por: Gómez-Ochoa, Sergio Alejandro, et al.
Publicado: (2022)

Myocardial Involvement in Chagas Disease and Insulin Resistance: A Non-Metabolic Model of Cardiomyopathy
por: Echeverría, Luis E., et al.
Publicado: (2020)

Global, Regional, and National Trends of Chagas Disease from 1990 to 2019: Comprehensive Analysis of the Global Burden of Disease Study
por: Gómez-Ochoa, Sergio Alejandro, et al.
Publicado: (2022)

Longitudinal Speckle Tracking Strain Abnormalities in Chagas Disease: A Systematic Review and Meta-Analysis
por: Gómez-Ochoa, Sergio Alejandro, et al.
Publicado: (2022)

Electrocardiographic abnormalities in Chagas disease in the general population: A systematic review and meta-analysis
por: Rojas, Lyda Z., et al.
Publicado: (2018)

Metabolomic Profiling of End-Stage Heart Failure Secondary to Chronic Chagas Cardiomyopathy
por: Díaz, Martha Lucía, et al.
Publicado: (2022)

Efficacy of the Benznidazole+Posaconazole combination therapy in parasitemia reduction: An experimental murine model of acute Chagas
por: Echeverría, Luis Eduardo, et al.
Publicado: (2020)

The Characterization of Cardiac Explants Reveals Unique Fibrosis Patterns and a Predominance of CD8+ T Cell Subpopulations in Patients with Chronic Chagas Cardiomyopathy
por: Díaz, Martha Lucía, et al.
Publicado: (2022)

Clinical Presentations of Chagas Cardiomyopathy
por: Shehadeh, Malik, et al.
Publicado: (2020)

Determinants and Predictors of Grief Severity and Persistence: The Rotterdam Study
por: Milic, Jelena, et al.
Publicado: (2017)

Two-dimensional strain derived parameters provide independent predictors of progression to Chagas cardiomyopathy and mortality in patients with Chagas disease
por: Saraiva, Roberto M., et al.
Publicado: (2022)

Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis
por: Taneri, Petek Eylul, et al.
Publicado: (2020)

Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis
por: Glisic, Marija, et al.
Publicado: (2018)

COVID-19: Implications for People with Chagas Disease
por: Zaidel, Ezequiel José, et al.
Publicado: (2020)

WHF IASC Roadmap on Chagas Disease
por: Echeverría, Luis Eduardo, et al.
Publicado: (2020)

Treatment of Chagas Cardiomyopathy
por: Botoni, Fernando A., et al.
Publicado: (2013)

Chronic Chagas cardiomyopathy
por: Aiello, Vera Demarchi, et al.
Publicado: (2015)

Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysis
por: Ciapponi, Agustín, et al.
Publicado: (2020)

Chagas Cardiomyopathy Manifestations and Trypanosoma cruzi Genotypes Circulating in Chronic Chagasic Patients
por: Ramírez, Juan David, et al.
Publicado: (2010)

Prevalence of Chagas heart disease in dilated cardiomyopathy
por: González-Zambrano, Héctor, et al.
Publicado: (2021)

Congenital Chagas disease: an update
por: Carlier, Yves, et al.
Publicado: (2015)

CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973]
por: Quiros, Franklin R, et al.
Publicado: (2006)

Gene-diet interactions and cardiovascular diseases: a systematic review of observational and clinical trials
por: Roa-Díaz, Zayne M., et al.
Publicado: (2022)

Biomakers in Chronic Chagas Cardiomyopathy
por: Rodrigues, Angela Braga, et al.
Publicado: (2022)

Reduced-Exertion High-Intensity Interval Training as a Novel Therapeutic Approach for Insomnia
por: Atef, Hady, et al.
Publicado: (2021)

Misleading Meta-Analyses during COVID-19 Pandemic: Examples of Methodological Biases in Evidence Synthesis
por: Llanaj, Erand, et al.
Publicado: (2022)

Scientometrics analysis of research activity and collaboration patterns in Chagas cardiomyopathy
por: González-Alcaide, Gregorio, et al.
Publicado: (2018)

Chagas Disease Cardiomyopathy: Immunopathology and Genetics
por: Cunha-Neto, Edecio, et al.
Publicado: (2014)

Pathogenesis of Chagas Cardiomyopathy: Role of Inflammation and Oxidative Stress
por: Machado, Fabiana S., et al.
Publicado: (2013)

Early identification of patients with Chagas disease at risk of developing cardiomyopathy using 2-D speckle tracking strain: Win, Miranda prediction of Chagas cardiomyopathy
por: Win, Sithu, et al.
Publicado: (2022)

Age at Natural Menopause and Blood Pressure Traits: Mendelian Randomization Study
por: Roa-Díaz, Zayne M., et al.
Publicado: (2021)

Comprehensive analysis of three TYK2 gene variants in the susceptibility to Chagas disease infection and cardiomyopathy
por: Leon Rodriguez, Daniel A., et al.
Publicado: (2018)

Chagas Cardiomyopathy in the Context of the Chronic Disease Transition
por: Hidron, Alicia I., et al.
Publicado: (2010)

Cognitive dysfunction in chronic Chagas disease cardiomyopathy
por: Dias, Jesângeli Sousa, et al.
Publicado: (2009)

Comparison of 1-year healthcare resource utilization and related costs for patients with heart failure in the Chagas and non-Chagas matched cohorts
por: Olivera, Mario J., et al.
Publicado: (2022)

Determinants of minute ventilation-carbon dioxide production relationship in Chagas cardiomyopathy
por: Oliveira, Lucas Frois Fernandes, et al.
Publicado: (2021)

The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy
por: de Souza Pimentel, Walace, et al.
Publicado: (2012)

Imaging Diagnosis of Right Ventricle Involvement in Chagas Cardiomyopathy
por: Romano, Minna M. D., et al.
Publicado: (2017)

Advanced management of ventricular arrhythmias in chronic Chagas cardiomyopathy
por: Santacruz, David, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ks1pvqpke4673ko8gqiudcuhj2